Quoin Pharmaceuticals Investor Relations Material
Latest events
Q4 2023
Quoin Pharmaceuticals
Corporate Presentation
13 Jun, 2025
Q1 2025
13 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Quoin Pharmaceuticals Ltd
Access all reports
Quoin Pharmaceuticals Ltd is a U.S.-based specialty pharmaceutical company focused on the development and commercialization of therapeutic products for rare and orphan diseases. The company’s lead programs target conditions such as Netherton syndrome and other rare skin disorders. Quoin develops its drug candidates using proprietary delivery technologies and aims to address high unmet medical needs through both clinical research and strategic partnerships. The company is headquartered in Ashburn, Virginia, and its shares are listed on the NASDAQ.
Key slides for Quoin Pharmaceuticals Ltd
Corporate Presentation
Quoin Pharmaceuticals Ltd
Corporate Presentation
Quoin Pharmaceuticals Ltd
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
QNRX
Country
🇺🇸 United States